Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
AstraZeneca
Mallinckrodt
Johnson and Johnson
Express Scripts
Colorcon

Last Updated: November 19, 2019

DrugPatentWatch Database Preview

Litigation for FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE

See Plans and Pricing

« Back to Dashboard

US Court Litigation for FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE

Patent Trial and Appeal Board Cases for FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE

Patent Petitioner Status Filing Date Accorded Filing Date Patent Owner Trial Type Trial Number Decision Date Inventor Document Download
6,743,413 Mylan Pharmaceuticals Inc.   Start Trial 2015-09-29 2015-09-29 3M Company Inter partes review   Start Trial 2016-04-04 ROBERT SCHULZ   Start Trial
>Patent >Petitioner >Status >Filing Date >Accorded Filing Date >Patent Owner >Trial Type >Trial Number >Decision Date >Inventor >Document Download

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Harvard Business School
AstraZeneca
Express Scripts
Merck
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.